NCT03951220
The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss No drug interventions Not Available Not Available completed NCT05283993
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH No drug interventions Not Available Not Available recruiting NCT06140524
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma No drug interventions treatment 2 recruiting NCT02269592
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome No drug interventions Not Available Not Available recruiting NCT05640843
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) No drug interventions prevention Not Available recruiting NCT06046287
Daratumumab for Polyneuropathy Associated With MGUS treatment 2 recruiting NCT00099047
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma prevention 2 completed NCT03119883
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma No drug interventions basic_science Not Available completed NCT05114109
Isatuximab in Type I Cryoglobulinemia treatment 2 unknown_status NCT00025415
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction treatment 1 completed NCT04702932
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies No drug interventions Not Available Not Available not_yet_recruiting NCT06489613
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology. No drug interventions Not Available Not Available not_yet_recruiting NCT02298816
B-Cell Hematologic Malignancy Vaccination Registry No drug interventions Not Available Not Available withdrawn NCT00919139
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. No drug interventions Not Available Not Available completed NCT01408225
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource No drug interventions Not Available Not Available recruiting NCT06472830
Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) Among Unique Populations of Black People No drug interventions Not Available Not Available enrolling_by_invitation NCT01079429
Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. No drug interventions Not Available Not Available terminated NCT04615572
Screening to Improve Survival in AL Amyloidosis No drug interventions Not Available Not Available completed NCT04850846
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma No drug interventions treatment 2 active_not_recruiting NCT01955395
Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma No drug interventions supportive_care Not Available completed NCT02726750
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma No drug interventions Not Available Not Available recruiting NCT06383143
Promoting Diagnosis and Management of AL in Italy (ProDigALIty) No drug interventions Not Available Not Available recruiting NCT05969821
Clonal Hematopoiesis of Immunological Significance No drug interventions Not Available Not Available not_yet_recruiting NCT04114084
Sleep Apnea in Patients With MGUS and MM No drug interventions Not Available Not Available recruiting NCT04920084
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) No drug interventions prevention Not Available active_not_recruiting NCT06559033
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS No drug interventions Not Available Not Available not_yet_recruiting NCT01237054
Imaging in MGUS, SMM and MM No drug interventions diagnostic 2 completed NCT00899353
Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) No drug interventions treatment 2 terminated NCT03327597
Iceland Screens, Treats or Prevents Multiple Myeloma No drug interventions screening Not Available active_not_recruiting NCT03855878
Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery No drug interventions Not Available Not Available active_not_recruiting NCT05136807
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies No drug interventions Not Available Not Available recruiting NCT01109407
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) No drug interventions Not Available Not Available terminated NCT05965115
The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study No drug interventions Not Available Not Available recruiting NCT01588015
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant No drug interventions supportive_care 1 completed NCT04439006
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization No drug interventions treatment 1 completed NCT05831358
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program No drug interventions screening Not Available recruiting NCT01571726
Imaging Studies and the Development of Multiple Myeloma No drug interventions diagnostic 2 withdrawn NCT05361694
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions No drug interventions Not Available Not Available recruiting NCT04727294
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey No drug interventions Not Available Not Available unknown_status NCT04731844
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer No drug interventions treatment 2 recruiting NCT01219010
A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma No drug interventions treatment 1 completed